Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA
Authors
Keywords
Visfatin, NSCLC, CDDP, STAT3, TTP
Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 351, Issue -, Pages 109705
Publisher
Elsevier BV
Online
2021-10-16
DOI
10.1016/j.cbi.2021.109705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radiation exposure triggers the malignancy of non‑small cell lung cancer cells through the activation of visfatin/Snail signaling
- (2021) Liang Xiao et al. ONCOLOGY REPORTS
- LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
- (2020) Qingqiang Dai et al. Cancer Management and Research
- NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer
- (2019) Xin Ge et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis
- (2019) Tsung-Chieh Lin Cancer Management and Research
- Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin
- (2019) Zahra Bolandghamat Pour et al. BMC CANCER
- The Correlation of Visfatin and Its Gene Polymorphism with Non-Small Cell Lung Cancer
- (2018) Li-Juan Zhang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
- (2017) Misako Nagasaka et al. Expert Review of Anticancer Therapy
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
- (2017) James D McKay et al. NATURE GENETICS
- Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases
- (2016) Guanghai Wang et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Molecular mechanisms of synergistic induction of apoptosis by the combination therapy with hyperthermia and cisplatin in prostate cancer cells
- (2016) Jian-fu Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin
- (2016) Wenxia Hu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Dysregulation of TTP and HuR plays an important role in cancers
- (2016) Hao Wang et al. TUMOR BIOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Visfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
- (2015) Tingting Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Trials Integrating Immunotherapy and Radiation for Non–Small-Cell Lung Cancer
- (2015) Megan E. Daly et al. Journal of Thoracic Oncology
- RNA-stabilizing proteins as molecular targets in cardiovascular pathologies
- (2015) Sahana Suresh Babu et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach
- (2014) F. Rotolo et al. ANNALS OF ONCOLOGY
- STAT3, a key regulator of cell-to-cell communication in the heart
- (2014) Arash Haghikia et al. CARDIOVASCULAR RESEARCH
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Nampt/PBEF/visfatin and cancer
- (2010) Tie-qiang Bi et al. CANCER BIOLOGY & THERAPY
- Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study
- (2008) Ravi Retnakaran et al. CLINICAL ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now